SPOTLIGHT -
ARVO 2023: Lamina cribrosa pressure and predicting structural glaucoma progression
Ronald Zambrano, lab supervisor for the advanced Ophthalmic Imaging Lab at NYU Langone, talks about lamina cribrosa pressure and predicting structural glaucoma progression at this year's ARVO meeting.
ARVO 2023: Ocular blood flow and its relationship to acute coronary syndrome
Japanese investigators have found an ocular biomarker of cardiovascular diseases.
Ora Europe executive outlines pathway for clinical trials
Dr Sally Tucker of Ora Europe walks through the clinical trial pathway, describing how Ora addresses complexities to make the path as efficient as possible.
Phase 1 trial finds at-home subcutaneous injection option safe, effective for the treatment of wet AMD, DMO
Jeff Cleland, PhD, CEO of Ashvattha, discusses safety data for an at-home subcutaneous anti-VEGF injection option in development for the treatment of wet AMD and DMO.
